SPY317.23+0.18 0.06%
DIA261.55-1.45 -0.55%
IXIC10,505.79+72.14 0.69%

HC Wainwright & Co. Upgrades Evoke Pharma to Buy, Announces $10 Price Target

HC Wainwright & Co. analyst Ram Selvaraju upgrades Evoke Pharma (NASDAQ:EVOK) from Neutral to Buy and announces $10 price target.

Benzinga · -
HC Wainwright & Co. analyst Ram Selvaraju upgrades Evoke Pharma (NASDAQ: EVOK) from Neutral to Buy and announces $10 price target.